Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.030
-0.060 (-5.50%)
At close: Mar 20, 2026, 4:00 PM EDT
1.026
-0.004 (-0.41%)
After-hours: Mar 20, 2026, 7:59 PM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $14.2 million as of March 20, 2026. Its market cap has decreased by -18.87% in one year.
Market Cap
14.20M
Enterprise Value
8.05M
1-Year Change
-18.87%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $14.20M, a decrease of -87.69%. That is a compound annual growth rate of -22.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 15.00M | 11.11% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 15.63M |
| Intensity Therapeutics | 15.15M |
| AEON Biopharma | 14.77M |
| GT Biopharma | 14.52M |
| Jupiter Neurosciences | 14.29M |
| Hoth Therapeutics | 14.19M |
| Phio Pharmaceuticals | 14.17M |
| Cellectar Biosciences | 13.74M |